Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Lung disorder
ADR ID BADD_A02600
ADR Hierarchy
22      Respiratory, thoracic and mediastinal disorders
22.02      Respiratory disorders NEC
22.02.07      Respiratory tract disorders NEC
22.02.07.001      Lung disorder
Description Pathological processes involving any part of the LUNG. [MeSH]
MedDRA Code 10025082
MeSH ID D008171
ADR Severity Grade (FAERS) Not Available
ADR Severity Grade (CTCAE) Not Available
Synonym
Disorder lung | Disorder pulmonary | Lung disorder | Lung disorder NOS | Lung function abnormal | Lung involvement in conditions classified elsewhere | Lung involvement in other diseases classified elsewhere | Other alveolar and parietoalveolar pneumonopathy | Other alveolar and parietoalveolar pneumopathy | Other diseases of lung | Other diseases of lung, not elsewhere classified | Other specified alveolar and parietoalveolar pneumonopathies | Other specified alveolar and parietoalveolar pneumopathies | Other specified disease of lung | Other specified diseases of lung | Pulmonary disorder | Pulmonary function impairment | Unspecified alveolar and parietoalveolar pneumonopathy | Unspecified alveolar and parietoalveolar pneumopathy | Lung disorder (NOS) | Pneumopathy | Lung disease | Lung Diseases | Disease, Lung | Diseases, Lung | Lung Disease | Pulmonary Disease | Disease, Pulmonary | Diseases, Pulmonary | Pulmonary Diseases
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D02423Fondaparinux0.004934%
BADD_D02432Glycopyrronium0.005674%
BADD_D02439Levodopa0.000807%
BADD_D02443Tiotropium0.001040%
BADD_D02445Solifenacin0.000174%
BADD_D02465Aclidinium0.001476%
BADD_D02470Nintedanib0.000895%
BADD_D02471Oxygen0.003717%
BADD_D02473Sodium chloride--
BADD_D02480Alectinib0.000728%
BADD_D02483Ribociclib0.000336%
BADD_D02487Baricitinib0.001181%
BADD_D02492Deflazacort0.000151%
BADD_D02498Abemaciclib0.000526%
BADD_D02504Lorlatinib0.000582%
BADD_D02505Gilteritinib0.000302%
BADD_D02509Brigatinib0.001075%
BADD_D02517Enasidenib0.000112%
BADD_D02526Larotrectinib0.000224%
BADD_D02577Oseltamivir acid0.000744%
BADD_D02585Pralsetinib0.000112%
BADD_D02599Tepotinib0.000112%
BADD_D02603Tucatinib0.000112%
The 9th Page    First    Pre   9    Total 9 Pages
ADReCS-Target
ADR Term Drug Name Target